세계의 글루코스 바이오센서 시장 규모 조사 : 유형별, 최종 용도별, 지역별 예측(2022-2032년)

Global Glucose Biosensors Market is valued approximately at USD 11.7 billion in 2023 and is anticipated to grow with a growth rate of more than 8.20% over the forecast period 2024-2032. Glucose biosensors are analytical devices used to detect and measure glucose concentrations in various samples, most commonly in blood. These sensors integrate a biological component, such as an enzyme that specifically reacts with glucose, with a transducer that converts this biological response into a measurable electrical signal. They play a crucial role in diabetes management by allowing continuous monitoring of blood glucose levels, enabling timely adjustments in treatment to maintain optimal blood sugar control. Furthermore, Advances in miniaturization of devices are leading to the development of smaller, more portable glucose biosensors. These devices are easier to use on-the-go, enhancing their appeal to users with active lifestyles which are gaining attention towards Global Glucose Biosensors Market.

The Global Glucose Biosensors Market is driven by rising diabetes prevalence. Diabetic patients must regularly monitor their blood glucose levels to prevent complications, making glucose biosensors crucial for effective diabetes management. These devices measure blood glucose concentration and are indispensable for maintaining optimal health in diabetics. The demand for accurate, sensitive, and reliable glucose biosensors is high due to their critical role. Increased awareness of the importance of self-monitoring blood glucose levels, particularly among diabetic individuals, is fueling market growth. Continuous glucose monitoring systems (CGMS) have become increasingly popular because they offer real-time data, which helps achieve better glycemic control and reduces the risk of diabetes-related complications. However High costs associated with advanced glucose monitoring devices and concerns about data privacy and security associated with connected devices is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Glucose Biosensors market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the dominating regional market in terms of revenue. North America is the leading region in the global glucose biosensors market, primarily due to its well-established healthcare infrastructure and high prevalence of diabetes. The region benefits from significant investments in healthcare technology and research, which drive innovation and the adoption of advanced glucose monitoring systems. Additionally, strong regulatory frameworks and favorable reimbursement policies in countries like the United States enhance access to these devices. The presence of major market players and widespread awareness about the importance of diabetes management further bolster the market in North America. The growing trend of integrating glucose biosensors with wearable technology and the increasing use of continuous glucose monitoring systems (CGMS) contribute to the region's leading position across the region. Furthermore, the market in Asia Pacific, on the other hand, is expected to grow at the fastest rate over the forecast period 2024-2032.

Major market player included in this report are:

• Abbott Laboratories
• ACON Laboratories, Inc.
• AgaMatrix Inc.
• Bayer AG
• GE Healthcare Limited
• BioSense Medical Devices, LLC
• Biosensors International Pte. Ltd.
• LifeScan, Inc.
• LifeSensors, Inc.
• Medtronic, Inc.

The detailed segments and sub-segment of the market are explained below:

By Type

• Electrochemical Biosensor
• Optical Biosensor
• Others

By End Use

• Hospitals
• Homecare
• Diagnostic Center

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Glucose Biosensors Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global Glucose Biosensors Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Type
  • 2.3.2. By End Use
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Glucose Biosensors Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global Glucose Biosensors Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economic
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Glucose Biosensors Market Size & Forecasts by Type 2022-2032

• 5.1. Electrochemical Biosensor
• 5.2. Optical Biosensor
• 5.3. Others

Chapter 6. Global Glucose Biosensors Market Size & Forecasts by End Use 2022-2032

• 6.1. Hospitals
• 6.2. Homecare
• 6.3. Diagnostic Center

Chapter 7. Global Glucose Biosensors Market Size & Forecasts by Region 2022-2032

• 7.1. North America Glucose Biosensors Market
  • 7.1.1. U.S. Glucose Biosensors Market
    • 7.1.1.1. Type breakdown size & forecasts, 2022-2032
    • 7.1.1.2. End Use breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Glucose Biosensors Market
• 7.2. Europe Glucose Biosensors Market
  • 7.2.1. U.K. Glucose Biosensors Market
  • 7.2.2. Germany Glucose Biosensors Market
  • 7.2.3. France Glucose Biosensors Market
  • 7.2.4. Spain Glucose Biosensors Market
  • 7.2.5. Italy Glucose Biosensors Market
  • 7.2.6. Rest of Europe Glucose Biosensors Market
• 7.3. Asia-Pacific Glucose Biosensors Market
  • 7.3.1. China Glucose Biosensors Market
  • 7.3.2. India Glucose Biosensors Market
  • 7.3.3. Japan Glucose Biosensors Market
  • 7.3.4. Australia Glucose Biosensors Market
  • 7.3.5. South Korea Glucose Biosensors Market
  • 7.3.6. Rest of Asia Pacific Glucose Biosensors Market
• 7.4. Latin America Glucose Biosensors Market
  • 7.4.1. Brazil Glucose Biosensors Market
  • 7.4.2. Mexico Glucose Biosensors Market
  • 7.4.3. Rest of Latin America Glucose Biosensors Market
• 7.5. Middle East & Africa Glucose Biosensors Market
  • 7.5.1. Saudi Arabia Glucose Biosensors Market
  • 7.5.2. South Africa Glucose Biosensors Market
  • 7.5.3. Rest of Middle East & Africa Glucose Biosensors Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Abbott Laboratories
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. ACON Laboratories, Inc.
  • 8.3.3. AgaMatrix Inc.
  • 8.3.4. Bayer AG
  • 8.3.5. GE Healthcare Limited
  • 8.3.6. BioSense Medical Devices, LLC
  • 8.3.7. Biosensors International Pte. Ltd.
  • 8.3.8. LifeScan, Inc.
  • 8.3.9. LifeSensors, Inc.
  • 8.3.10. Medtronic, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes